157 related articles for article (PubMed ID: 9419769)
1. Pathogenesis of ovarian cancers.
Berchuck A; Elbendary A; Havrilesky L; Rodriguez GC; Bast RC
J Soc Gynecol Investig; 1994; 1(3):181-90. PubMed ID: 9419769
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers in the ovary.
Berchuck A
J Cell Biochem Suppl; 1995; 23():223-6. PubMed ID: 8747400
[TBL] [Abstract][Full Text] [Related]
3. Human ovarian cancer of the surface epithelium.
Berchuck A; Carney M
Biochem Pharmacol; 1997 Sep; 54(5):541-4. PubMed ID: 9337069
[TBL] [Abstract][Full Text] [Related]
4. Cell growth regulation in epithelial ovarian cancer.
Bast RC; Boyer CM; Jacobs I; Xu FJ; Wu S; Wiener J; Kohler M; Berchuck A
Cancer; 1993 Feb; 71(4 Suppl):1597-601. PubMed ID: 8431895
[TBL] [Abstract][Full Text] [Related]
5. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review).
Aunoble B; Sanches R; Didier E; Bignon YJ
Int J Oncol; 2000 Mar; 16(3):567-76. PubMed ID: 10675491
[TBL] [Abstract][Full Text] [Related]
6. Oncogenes in ovarian cancer.
Berchuck A; Kohler MF; Bast RC
Hematol Oncol Clin North Am; 1992 Aug; 6(4):813-27. PubMed ID: 1500387
[TBL] [Abstract][Full Text] [Related]
7. The molecular basis of ovarian cancer.
Gallion HH; Pieretti M; DePriest PD; van Nagell JR
Cancer; 1995 Nov; 76(10 Suppl):1992-7. PubMed ID: 8634990
[TBL] [Abstract][Full Text] [Related]
8. [Alterations of c-Myc and c-erbB-2 genes in ovarian tumours].
Pastor T; Popović B; Gvozdenović A; Boro A; Petrović B; Novaković I; Puzović D; Luković L; Milasin J
Srp Arh Celok Lek; 2009; 137(1-2):47-51. PubMed ID: 19370966
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and significance of HER-2/neu amplification in epithelial ovarian cancer.
Wong YF; Cheung TH; Lam SK; Lu HJ; Zhuang YL; Chan MY; Chung TK
Gynecol Obstet Invest; 1995; 40(3):209-12. PubMed ID: 8529957
[TBL] [Abstract][Full Text] [Related]
10. Oncogenesis in ovarian cancer.
Børresen AL
Acta Obstet Gynecol Scand Suppl; 1992; 155():25-30. PubMed ID: 1502889
[TBL] [Abstract][Full Text] [Related]
11. [Genetic alterations in the genesis and development of ovarian cancer].
Okamoto A; Yokoyama S; Terashima Y
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1971-6. PubMed ID: 1358031
[TBL] [Abstract][Full Text] [Related]
12. Molecular and biologic factors in the pathogenesis of ovarian cancer.
Berek JS; Martínez-Maza O
J Reprod Med; 1994 Apr; 39(4):241-8. PubMed ID: 8040839
[TBL] [Abstract][Full Text] [Related]
13. The biology of ovarian cancer.
Boente MP; Hurteau J; Rodriguez GC; Bast RC; Berchuck A
Curr Opin Oncol; 1993 Sep; 5(5):900-7. PubMed ID: 8218503
[TBL] [Abstract][Full Text] [Related]
14. Expression of cell regulatory proteins in ovarian borderline tumors.
van Haaften-Day C; Russell P; Boyer CM; Kerns BJ; Wiener JR; Jensen DN; Bast RC; Hacker NF
Cancer; 1996 May; 77(10):2092-8. PubMed ID: 8640675
[TBL] [Abstract][Full Text] [Related]
15. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of endometrial cancer.
Berchuck A; Boyd J
Cancer; 1995 Nov; 76(10 Suppl):2034-40. PubMed ID: 8634996
[TBL] [Abstract][Full Text] [Related]
17. Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu.
Hakim AA; Barry CP; Barnes HJ; Anderson KE; Petitte J; Whitaker R; Lancaster JM; Wenham RM; Carver DK; Turbov J; Berchuck A; Kopelovich L; Rodriguez GC
Cancer Prev Res (Phila); 2009 Feb; 2(2):114-21. PubMed ID: 19174584
[TBL] [Abstract][Full Text] [Related]
18. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology of colorectal cancer.
Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
[TBL] [Abstract][Full Text] [Related]
20. HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma.
Afify AM; Werness BA; Mark HF
Exp Mol Pathol; 1999 Jun; 66(2):163-9. PubMed ID: 10409445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
